Influenza vaccination for patients with chronic obstructive pulmonary disease: Understanding immunogenicity, efficacy and effectiveness

Therapeutic Advances in Respiratory Disease

Volumn 10, Issue 4, 2016, Pages 349-367

  Sanei, Farzaneh ^a   Wilkinson, Tom ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

chronic obstructive pulmonary disease; influenza; vaccine

Indexed keywords

CORTICOSTEROID; INFLUENZA VACCINE;

AGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSENESCENCE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MEASUREMENT; MORTALITY; NONHUMAN; NUTRITIONAL ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; REVIEW; SMOKING; AGE; AGED; B LYMPHOCYTE; COMPLICATION; IMMUNOLOGY; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE;

AGE FACTORS; AGED; B-LYMPHOCYTES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES;

EID: 84979270698     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465816646050     Document Type: Review

References (111)

1. Advisory Group on Pulmonary Function Tests in Relation to Live Influenza Virus Vaccines. (1980) A study of live influenza virus vaccine in patients with chronic bronchitis. Report to Medical Research Council's committee on influenza and other respiratory virus vaccines. British Journal of Diseases of the Chest 74: 121-127.
2. Ambrose C., Levin M., Belshe R., (2011) The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respir Viruses 5: 67-75.
3. Aniwidyaningsih W., Varraso R., Cano N., Pison C., (2008) Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene. Curr Opin Clin Nutr Metab Care 11: 435-442.
4. Anzueto A., (2010) Impact of exacerbations on COPD. Eur Respir Rev 19: 113-118.
5. Aspinall R., Del Giudice G., Effros R., Grubeck-Loebenstein B., Sambhara S., (2007) Challenges for vaccination in the elderly. Immun Ageing 4: 9.
6. Baxter R., Lee J., Fireman B., (2010). Evidence of bias studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 201: 186-189.
7. Belshe R., (2010) The need for quadrivalent vaccine against seasonal influenza. Vaccine 28 (Suppl. 4): D45-D53.
8. Birrell M., Wong S., Catley M., Belvisi M., (2008) Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 214: 27-37.
9. Britton M., (2003) The burden of COPD in the U.K.: results from the confronting COPD survey. Respir Med 97 (Suppl. C): S71-S79.
10. Burel J., Nath K., Pritchard A., White O., Davies J., Towers M., et al. (2012) Evaluation of immune responses to influenza vaccination in chronic obstructive pulmonary disease. J Vaccines Vaccination 4: 1-7.
11. Burge S., Wedzicha J., (2003) COPD Exacerbations: definitions and classifications. Eur Respir J Suppl 41: 46s-53s.
12. Carrat F., Flahault A., (2007) Influenza vaccine: the challenge of antigenic drift. Vaccine 25: 6852-6862.
13. Cate T., Kasel J., Couch R., Six H., Knight V., (1977) Clinical trials of bivalent influenza/A/New Jersey/76-A/Victoria/75 vaccines in the elderly. J Infect Dis 136 (Suppl.): S518-S525.
14. CDC. (2015a) Quadrivalent Influenza Vaccine. Available at: http://www.cdc.gov/flu/protect/vaccine/quadrivalent.htm (. accessed 6 January 2016).
15. CDC. (2015b) Selecting the Viruses in the Seasonal Influenza (Flu) Vaccine. Available at: http://www.cdc.gov/flu/professionals/vaccination/virusqa.htm (. accessed 9 January 2016).
16. Chavance M., Herbeth B., Mikstacki T., Fournier C., Vernhes G., Janot C., (1985) Nutritional support improves antibody response to influenza virus vaccine in the elderly. Br Med J (Clin Res Ed) 291: 1348-1349.
17. Cox R., Brokstad K., Ogra P., (2004) Influenza virus: immunity and vaccination strategies. comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59: 1-15.
18. Cruijff M., Thijs C., Govaert T., Aretz K., Dinant G., Knottnerus A., (1999) The effect of smoking on influenza, influenza vaccination efficacy and on the antibody response to influenza vaccination. Vaccine 17: 426-432.
19. Darvishian M., Bijlsma M., Hak E., Van Den Heuvel E., (2014) Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis 14: 1228-1239.
20. Darvishian M., Gefenaite G., Turner R., Pechlivanoglou P., Van Der Hoek W., Hak E., (2014) After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol 67: 734-744.
21. De Roux A., Marx A., Burkhardt O., Schweiger B., Borkowski A., Banzhoff A., et al. (2006) Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. Vaccine 24: 1537-1542.
22. Doherty D., Briggs D., (2004) Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis. Clin Cornerstone 6: S5-S16.
23. Donaldson G., Wedzicha J., (2006) COPD Exacerbations. 1: Epidemiology. Thorax 61: 164-168.
24. Ezzell L., Jensen G., (2000) Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr 72: 1415-1416.
25. Faner R., Rojas M., Macnee W., Agustí A., (2012) Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 186: 306-313.
26. Fell P., O'Donnell H., Watson N., Simmins R., Hasell S., (1977) Longer term effects of live influenza vaccine in patients with chronic pulmonary disease. Lancet 1: 1282-1284.
27. Finklea J., Hasselblad V., Riggan W., Nelson W., Hammer D., Newill V., (1971) Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. Am Rev Respir Dis 104: 368-376.
28. Furumoto A., Ohkusa Y., Chen M., Kawakami K., Masaki H., Sueyasu Y., et al. (2008) Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 26: 4284-4289.
29. GOLD. (2016) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available at: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html (. accessed 12 February 2016).
30. Goodwin K., Viboud C., Simonsen L., (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-1169.
31. Gorse G., Campbell M., Otto E., Powers D., Chambers G., Newman F., (1995) Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly withlive attenuated or inactivated influenza virus vaccine. J Infect Dis 172: 1-10.
32. Gorse G., O'Connor T., Young S., Mendelman P., Bradley S., Nichol K., et al. (2003) Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 21: 2133-2144.
33. Gorse G., Otto E., Daughaday C., Newman F., Eickhoff C., Powers D., et al. (1997) Influenza virus vaccination of patients with chronic lung disease. Chest 112: 1221-1233.
34. Govaert M., Dinant G., Aretz K., Masurel N., Sprenger M., Knottnerus J., (1993) Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. Br Med J 307: 988-990.
35. Govaert T., Sprenger M., Dinant G., Aretz K., Masurel N., Knottnerus J., (1994a) Immune response to influenza vaccination of elderly people. a randomized double-blind placebo-controlled trial. Vaccine 12: 1185-1189.
36. Govaert M., Thijs C., Masurel N., Sprenger J., Dinant G., Knottnerus J., (1994b) The efficacy of Inflenza vaccination in elderly individuals. A randomised double-blind placebo controlled trial. J Am Med Assoc 272: 1661-1665.
37. Gupta B., Kant S., Mishra R., Verma S., (2010) Nutritional status of chronic obstructive pulmonary disease patients admitted in hospital with acute exacerbation. J Clin Med Res 2: 68-74.
38. Hallin R., Gudmundsson G., Suppli Ulrik C., Nieminen M., Gislason T., Lindberg E., et al. (2007) Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 101: 1954-1960.
39. Hanania N., Sockrider M., Castro M., Holbrook J., Tonascia J., Wise R., et al. (2004) Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy. J Allergy Clin Immunol 113: 717-724.
40. Hara M., Tanaka K., Hirota Y., (2005) Immune response to influenza vaccine in healthy adults and the elderly: association with nutritional status. Vaccine 23: 1457-1463.
41. He W., Wang W., Han H., Wang L., Zhang G., Gao B., (2013) Molecular basis of live-attenuated influenza virus. PLoS One 8: e60413.
42. He X., Holmes T., Zhang C., Mahmood K., Kemble G., Lewis D., et al. (2006) Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80: 11756-11766.
43. Hovden A., Cox R., Haaheim L., (2007) Influenza: the virus and prophylaxis with inactivated influenza vaccine in 'at risk' groups, including COPD patients. Int J Chron Obstruct Pulmon Dis 2: 229-240.
44. Howells C., Tyler L., (1961) Prophylactic use of influenza vaccine in patients with chronic bronchitis. A pilot trial. Lancet 2: 1428-1432.
45. Hsieh M., Yang T., Tsai Y., (2016) Nutritional supplementation in patients with chronic obstructive pulmonary disease. J Formos Med Assoc: xx, 1-7
46. Hsu A., Starkely M., Hanish I., Parsons K., Haw T., Howland L., (2015) Targeting PI3K-P110A suppresses influenza virus infection in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 191: 1012-1023.
47. Inoue S., Takabatake N., Igarashi A., Shuichi A., Isao K., (2013) Influence of corticosteroid therapy on the serum antibody response to influenza vaccine in elderly patients with chronic pulmonary diseases. EXCLI J 12: 760-765.
48. Ito K., Barnes P., (2009) COPD as a disease of accelerated lung aging. Chest 135: 173-180.
49. Izurieta H., Thadani N., Shay D., Lu Y., Maurer A., Foppa I., et al. (2015) Comparative effectiveness of high-dose versus standard-dose influenza vaccines in us residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis 15: 293-300.
50. Jackson L., Jackson M., Nelson J., Neuzil K., Weiss N., (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35: 337-344.
51. Kahan S., Wherry E., Zajac A., (2015) T cell exhaustion during persistent viral infections. Virology 479-480: 180-193.
52. Kalathil S., Lugade A., Pradhan V., Miller A., Parameswaran G., Sethi S., et al. (2014) T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 190: 40-50.
53. Kalra R., Singh S., Savage S., Finch G., Sopori M., (2000) Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive Ca(2+) stores. J Pharmacol Exp Ther 293: 166-171.
54. Kanner R., Connett J., Williams D., Buist A., (1999) Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 106: 410-416.
55. Kim J., Skountzou I., Compans R., Jacob J., (2009) Original antigenic Sin responses to influenza viruses. J Immunol 183: 3294-3301.
56. Kubiet M., Gonzalez-Rothi R., Cottey R., Bender B., (1996) Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest 110: 367-370.
57. Lall D., Cason E., Pasquel F., Ali M., Narayan K., (2016) Effectiveness of influenza vaccination for individuals with chronic obstructive pulmonary disease (COPD) in low- and middle-income countries. COPD 13: 93-99.
58. Lambert L., Fauci A., (2010) Influenza vaccines for the future. N Engl J Med 363: 2036-2044.
59. Lambert N., Ovsyannikova I., Pankratz V., Jacobson R., Poland G., (2012) Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines 11: 985-994.
60. Landis S., Muellerova H., Mannino D., Menezes A., Han M., Van Der Molen T., et al. (2014) Continuing to confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013. Int J Chron Obstruct Pulmon Dis 9: 597-611.
61. Lange P., Groth S., Nyboe G., Mortensen J., Appleyard M., Jensen G., et al. (1989) Effects of smoking and Changes in smoking habits on the decline of FEV1. Eur Respir J 2: 811-816.
62. Lee B., Bartsch S., Willig A., (2012) The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 30: 7443-7446.
63. Lundbäck B., Lindberg A., Lindström M., Rönmark E., Jonsson A., Jönsson E., et al. (2003) Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden studies. Respir Med 97: 115-122.
64. Makris D., Moschandreas J., Damianaki M., Ntaoukakis A., Siafakaa E., Milic N., et al. (2007) Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Resp Med 101: 1305-1312.
65. Mallia P., Johnston S., (2007) Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis 2: 55-64.
66. Medical Research Council. (1980) A study of live influenza virus vaccine in patients with chronic bronchitis. Report to Medical Research Council's committee on influenza and other respiratory virus vaccines. Advisory Group on Pulmonary Function Tests in Relation to Live Influenza Virus Vaccines. Br J Dis Chest 74: 121-127.
67. McElhaney J., (2005) The unmet need in the elderly: designing new influenza vaccines for older adults. Vaccine 23 (Suppl. 1): S10-S25.
68. McElhaney J., (2011) Influenza vaccine responses in older adults. Ageing Res Rev 10: 379-388.
69. McElhaney J., Xie D., Hager W., Barry M., Wang Y., Kleppinger A., et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
70. McKendry R., Spalluto C., Burke H., Nicholas B., Cellura D., Al-Shamkhani A., et al. (2015) Dysregulation of anti-viral function of CD8+T cells in the COPD lung: role of the PD1/PDl1 axis. Am J Respir Crit Care Med 193: 642-651.
71. Monto A., Hornbuckle K., Ohmit S., (2001) Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 154: 155-160.
72. Nath K., Burel J., Shankar V., Pritchard A., Towers M., Looke D., et al. (2014) Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 9: 51-56.
73. Neuzil K., O'Connor T., Gorse G., Nichol K., (2003) Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clin Infect Dis 36: 169-174.
74. NICE (2010) Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care (Partial Update). London: NICE.
75. NICE (2015) Immunizations-Seasonal Infleunza. London: NICE.
76. Nichol K., Baken L., Nelson A., (1999) Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 130: 397.
77. Papi A., Luppi F., Franco F., Fabbri L., (2006) Pathophysiology of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 3: 245-251.
78. Polosukhin V., Cates J., Lawson W., Zaynagetdinov R., Milstone A., Massion P., et al. (2011) Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 184: 317-327.
79. Poole P., Chacko E., Wood-Baker R., Cates C., (2006) Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev: CD002733.
80. Potter C., Oxford J., (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35: 69-75.
81. Pride N., (2001) Smoking cessation: effects on symptoms, spirometry and future trends in COPD. Thorax 56 (Suppl. 2): ii7-ii10.
82. Raherison C., Girodet P., (2009) Epidemiology of COPD. Eur Respir Rev 18: 213-221.
83. Ramsey S., Hobbs F., (2006) Chronic obstructive pulmonary disease, risk factors, and outcome trials. Proc Am Thorac Soc 3: 635-640.
84. Sapey E., Stockley R., (2006) COPD exacerbations. 2: Aetiology. Thorax 61: 250-258.
85. Sasaki S., Sullivan M., Narvaez C., Holmes T., Furman D., Zheng N., et al. (2011) Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 121: 3109-3119.
86. Schembri S., Morant S., Winter J., Macdonald T., (2009) Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 64: 567-572.
87. Schleimer R., (2005) Innate immune responses and chronic obstructive pulmonary disease: 'Terminator' or 'Terminator 2'? Proc Am Thorac Soc 2: 342-346; discussion 341-342.
88. Seemungal T., Donaldson G., Paul E., Bestall J., Jeffries D., Wedzicha J., (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418-1422.
89. Sehatzadeh S., (2012) Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-vased review. Ont Health Technol Assess Ser 12: 1-64.
90. Sethi S., (2010) Infection as a comorbidity of COPD. Eur Respir J 35: 1209-1215.
91. Shahab L., Jarvis M., Britton J., West R., (2006) Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 61: 1043-1047.
92. Sobolev O., Binda E., O'Farrell S., Lorenc A., Pradines J., Huang Y., et al. (2016) Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol 17: 204-213.
93. Sopori M., (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2: 372-377.
94. Stämpfli M., Anderson G., (2009) How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol 9: 377-384.
95. Stephenson I., Nicholson K., (2001) Influenza: vaccination and treatment. Eur Respir J 17: 1282-1293.
96. Ting S., Crooks S., South G., (2011) The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period. J Epidemiol Community Health 65: 157-159.
97. Treanor J., Dumyati G., O'Brien D., Riley M., Riley G., Erb S., et al. (1994) Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. J Infect Dis 169: 402-407.
98. Treanor J., Mattison H., Dumyati G., Yinnon A., Erb S., O'Brien D., et al. (1992) Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 117: 625-633.
99. Trtica-Majnaric L., Sarlija N., Vitale B., (2012) Modelling influenza vaccination outcomes. World J Vaccines 2: 12-20.
100. Vermeeren M., Wouters E., Geraerts-Keeris A., Schols A., (2004) Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. Clin Nutr 23: 1184-1192.
101. Wang C., Wang S., Lai C., Lin L., Chou P., (2007) Impact of influenza vaccination on major cause-specific mortality. Vaccine 25: 1196-1203.
102. Wedzicha J., Donaldson G., (2003) Exacerbations of chronic obstructive pulmonary disease. Respir Care 48: 1204-1213; discussion 1213-1215.
103. Weinberger B., Herndler-Brandstetter D., Schwanninger A., Weiskopf D., Grubeck-Loebenstein B., (2008) Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 46: 1078-1084.
104. Wesseling G., (2007) Occasional review: influenza in COPD: pathogenesis, prevention, and treatment. Int J Chron Obstruct Pulmon Dis 2: 5-10.
105. Wherry E., (2011) T cell exhaustion. Nat Immunol 12: 492-499.
106. WHO (2015) Vaccine Effectiveness Estimates for Seasonal Influenza Vaccines. Geneva: WHO.
107. Wilson R., (2001) Bacteria, antibiotics and COPD. Eur Respir J 17: 995-1007.
108. Wong S., Webby R., (2013) Traditional and new influenza vaccines. Clin Microbiol Rev 26: 476-492.
109. Wongsurakiat P., Maranetra K., Wasi C., Kositanont U., Dejsomritrutai W., Charoenratanakul S., (2004) Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 125: 2011-2020.
110. Xie H., Wan X., Ye Z., Plant E., Zhao Y., Xu Y., et al. (2015) H3N2 mismatch of 2014-15 northern hemisphere influenza vaccines and head-to-head comparison between human and ferret antisera derived antigenic maps. Sci Rep 5: 15279.
111. Yi J., Cox M., Zajac A., (2010) T-cell exhaustion: characteristics, causes and conversion. Immunology 129: 474-481.